Quantcast

New Lawsuit on NuvaRing Alleging Acute Pulmonary Embolism

June 11, 2012

According to court documents, on May 30th, 2012, an Iowa woman, Kristina Marie Isaac, filed a lawsuit in New Jersey District Court (case no. 2:2012cv03240) alleging that her NuvaRing caused her an acute pulmonary embolism. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix that was approved by the FDA in 2001. A study published on May 10th 2012 in the British Medical Journal revealed that women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. [http://www.attorneyone.com/nuva-ring-lawsuit/

San Diego, CA (PRWEB) June 11, 2012

The media spotlight is often a double-edged sword. No one knows this better than Kristina Marie Isaac. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on May 30th, 2012, an Iowa woman, Kristina Marie Isaac, filed a NuvaRing Lawsuit in New Jersey District Court (case no. 2:2012cv03240) alleging that her NuvaRing caused her an acute pulmonary embolism. NuvaRing is a popular internal birth control device, a vaginal ring placed near the cervix. It was approved by the FDA in October 2001 and it is marketed and sold by subsidiaries of Merck, Organon USA Inc. and Schering-Plough. In the lawsuit, the plaintiff claims she started using Nuvaring in May 2009 and in June 2010 she suffered an acute pulmonary embolism.

A study published on May 10th 2012 in the British Medical Journal revealed that women who use vaginal rings for contraception have a 6.5 times increased risk of confirmed venous thrombosis compared with non-users of hormonal contraception of the same age. As published on February 28th, 2012 in Merck & Co., Inc. form 10-K annual report for the fiscal year 2011, approximately 950 NuvaRing lawsuits were pending as of Dec. 31st 2011. The plaintiffs seek damages for injuries allegedly sustained from their NuvaRing use, including some alleged deaths, heart attacks and strokes.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of NuvaRing severe complications, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from NuvaRing remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In October 2011, the FDA published a study revealing that NuvaRing raised the risk of blood clots, including deep venous thrombosis (DVT) and pulmonary embolism (PE) by 56% when compared to older birth control pills.

AttorneyOne.com has further information on NuvaRing lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/6/prweb9578514.htm.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/6/prweb9590962.htm


Source: prweb



comments powered by Disqus